BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37212463)

  • 1. TRIM55 inhibits colorectal cancer development via enhancing protein degradation of c-Myc.
    Lin M; Fang Z; Lin X; Zhou W; Wang Y; Han S; Ye M; Zhu F
    Cancer Med; 2023 Jun; 12(12):13511-13521. PubMed ID: 37212463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.
    Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z
    J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The feedback loop of EFTUD2/c-MYC impedes chemotherapeutic efficacy by enhancing EFTUD2 transcription and stabilizing c-MYC protein in colorectal cancer.
    Zhu X; Li C; Gao Y; Zhang Q; Wang T; Zhou H; Bu F; Chen J; Mao X; He Y; Wu K; Li N; Luo H
    J Exp Clin Cancer Res; 2024 Jan; 43(1):7. PubMed ID: 38163859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Tripartite Motif Conaining 55 (TRIM55) Inhibits Migration and Invasion of Hepatocellular Carcinoma (HCC) Cells via Epithelial-Mesenchymal Transition and Matrix Metalloproteinase-2 (MMP2).
    Li X; Huang L; Gao W
    Med Sci Monit; 2019 Jan; 25():771-777. PubMed ID: 30685767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E3 ubiquitin ligase MAGI3 degrades c-Myc and acts as a predictor for chemotherapy response in colorectal cancer.
    Wang H; Yang W; Qin Q; Yang X; Yang Y; Liu H; Lu W; Gu S; Cao X; Feng D; Zhang Z; He J
    Mol Cancer; 2022 Jul; 21(1):151. PubMed ID: 35864508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-887-3p Inhibits the Progression of Colorectal Cancer via Downregulating DNMT1 Expression and Regulating P53 Expression.
    Teng D; Xia S; Hu S; Yan Y; Liu B; Yang Y; Du X
    Comput Intell Neurosci; 2022; 2022():7179733. PubMed ID: 35795731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
    Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
    Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM16 overexpression inhibits the metastasis of colorectal cancer through mediating Snail degradation.
    Ruan L; Liu W; Yang Y; Chu Z; Yang C; Yang T; Sun J
    Exp Cell Res; 2021 Sep; 406(1):112735. PubMed ID: 34265287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
    Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
    Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM55 Promotes Proliferation of Hepatocellular Carcinoma Through Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.
    Lu X; Yuan Y; Cai N; Rao D; Chen M; Chen X; Zhang B; Liang H; Zhang L
    J Hepatocell Carcinoma; 2023; 10():1281-1293. PubMed ID: 37554583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM55 suppresses malignant biological behavior of lung adenocarcinoma cells by increasing protein degradation of Snail1.
    Guo T; Zhang Z; Zhu L; Chen W; Ding Y; Li W; Huang Y; Huang J; Pan X
    Cancer Biol Ther; 2022 Dec; 23(1):17-26. PubMed ID: 34974792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-myc downstream-regulated gene 1 inhibits the proliferation of colorectal cancer through emulative antagonizing NEDD4-mediated ubiquitylation of p21.
    Zhang S; Yu C; Yang X; Hong H; Lu J; Hu W; Hao X; Li S; Aikemu B; Yang G; He Z; Zhang L; Xue P; Cai Z; Ma J; Zang L; Feng B; Yuan F; Sun J; Zheng M
    J Exp Clin Cancer Res; 2019 Dec; 38(1):490. PubMed ID: 31831018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HERC3 directly targets RPL23A for ubiquitination degradation and further regulates Colorectal Cancer proliferation and the cell cycle.
    Zhang Z; Wu Q; Fang M; Liu Y; Jiang J; Feng Q; Hu R; Xu J
    Int J Biol Sci; 2022; 18(8):3282-3297. PubMed ID: 35637966
    [No Abstract]   [Full Text] [Related]  

  • 14. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
    Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMAL1 promotes colorectal cancer cell migration and invasion through ERK- and JNK-dependent c-Myc expression.
    Shan L; Zheng W; Bai B; Hu J; Lv Y; Chen K; Wang X; Pan Y; Huang X; Zhu H; Dai S
    Cancer Med; 2023 Feb; 12(4):4472-4485. PubMed ID: 36806631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer.
    Jing Z; Liu Q; He X; Jia Z; Xu Z; Yang B; Liu P
    J Exp Clin Cancer Res; 2022 Jun; 41(1):198. PubMed ID: 35689245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.
    Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H
    Clin Epigenetics; 2019 Dec; 11(1):199. PubMed ID: 31888761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP38 inhibits colorectal cancer cell proliferation and migration via downregulating HMX3 ubiquitylation.
    Wang J; Gu Y; Yan X; Zhang J; Wang J; Ding Y
    Cell Cycle; 2023 May; 22(10):1169-1181. PubMed ID: 36204976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CIP2A and its mechanism of action in the malignant biological behavior of colorectal cancer.
    Chen W; Liang JL; Zhou K; Zeng QL; Ye JW; Huang MJ
    Cell Commun Signal; 2020 Apr; 18(1):67. PubMed ID: 32321509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation.
    Liu C; Wang L; Liu X; Tan Y; Tao L; Xiao Y; Deng P; Wang H; Deng Q; Lin Y; Jie H; Zhang H; Zhang J; Peng Y; Zhang H; Zhou Z; Sun Q; Cen X; Zhao Y
    Theranostics; 2021; 11(6):2966-2986. PubMed ID: 33456583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.